Goldman Sachs’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-400
Closed -$11K 5860
2017
Q4
$11K Hold
400
﹤0.01% 6189
2017
Q3
$11K Sell
400
-100
-20% -$2.21K ﹤0.01% 6519
2017
Q2
$10K Buy
+500
New +$10.6K ﹤0.01% 6650

Other funds holding ACLS

Goldman Sachs's ACLS Position: Q1 2026 in Review

Goldman Sachs reduced its Axcelis (ACLS) stake by 21% in Q1 2026, selling an estimated $11.7M and leaving 497,624 shares worth $46.3M. The position accounts for 0.01% of the portfolio, ranked #1639.

Goldman Sachs first reported a position in ACLS in Q2 2013 and has held it in 52 quarters since. The position peaked at $99.9M in Q2 2024. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Goldman Sachs held 497,624 shares of Axcelis worth $46.3M as of Q1 2026.
  • Goldman Sachs sold 132,190 Axcelis shares in Q1 2026, an estimated $11.7M.
  • Axcelis made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1639 holding.
  • Goldman Sachs first reported a position in Axcelis in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Axcelis position peaked at $99.9M in Q2 2024.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.